These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 24215359)

  • 21. Implantable cardiac device procedures in older patients: use and in-hospital outcomes.
    Swindle JP; Rich MW; McCann P; Burroughs TE; Hauptman PJ
    Arch Intern Med; 2010 Apr; 170(7):631-7. PubMed ID: 20386008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevated B-type natriuretic peptide is associated with increased in-hospital mortality or cardiac arrest in patients undergoing implantable cardioverter-defibrillator implantation.
    Wei S; Loyo-Berríos NI; Haigney MC; Cheng H; Pinnow EE; Mitchell KR; Beachy JH; Woodward AM; Wang Y; Curtis JP; Marinac-Dabic D
    Circ Cardiovasc Qual Outcomes; 2011 May; 4(3):346-54. PubMed ID: 21487093
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Body mass index and outcome after ventricular assist device placement.
    Musci M; Loforte A; Potapov EV; Krabatsch T; Weng Y; Pasic M; Hetzer R
    Ann Thorac Surg; 2008 Oct; 86(4):1236-42. PubMed ID: 18805168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative effectiveness of cardiac resynchronization therapy with an implantable cardioverter-defibrillator versus defibrillator therapy alone: a cohort study.
    Masoudi FA; Mi X; Curtis LH; Peterson PN; Curtis JP; Fonarow GC; Hammill SC; Heidenreich PA; Al-Khatib SM; Piccini JP; Qualls LG; Hernandez AF
    Ann Intern Med; 2014 May; 160(9):603-11. PubMed ID: 24798523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Obese female patients have higher rates of lead dislodgement after ICD or CRT-D implantation.
    Kawata H; Patel J; McGarry T; Joshi R; Krummen D; Feld G; Birgersdotter-Green U
    Int J Cardiol; 2014 Apr; 172(3):e522-4. PubMed ID: 24502881
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical effectiveness of cardiac resynchronization and implantable cardioverter-defibrillator therapy in men and women with heart failure: findings from IMPROVE HF.
    Wilcox JE; Fonarow GC; Zhang Y; Albert NM; Curtis AB; Gheorghiade M; Heywood JT; Mehra MR; O'Connor CM; Reynolds D; Walsh MN; Yancy CW
    Circ Heart Fail; 2014 Jan; 7(1):146-53. PubMed ID: 24178311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between New York Heart Association class change and ventricular tachyarrhythmia occurrence in patients treated with cardiac resynchronization plus defibrillator.
    Lepillier A; Piot O; Gerritse B; Copie X; Lavergne T; Paziaud O; Lascault G; Waintraub X; Otmani A; Le Heuzey JY
    Europace; 2009 Jan; 11(1):80-5. PubMed ID: 18952828
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study.
    Koller MT; Schaer B; Wolbers M; Sticherling C; Bucher HC; Osswald S
    Circulation; 2008 Apr; 117(15):1918-26. PubMed ID: 18391108
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical impact, safety, and efficacy of single- versus dual-coil ICD leads in MADIT-CRT.
    Kutyifa V; Huth Ruwald AC; Aktas MK; Jons C; McNitt S; Polonsky B; Geller L; Merkely B; Moss AJ; Zareba W; Bloch Thomsen PE
    J Cardiovasc Electrophysiol; 2013 Nov; 24(11):1246-52. PubMed ID: 23889863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiac device complications in the cognitively impaired.
    Jama A; Rabinstein A; Hodge D; Herges R; Asirvatham S; Cha YM; Powell B; Rea RF; Friedman P
    Pacing Clin Electrophysiol; 2013 Sep; 36(9):1061-7. PubMed ID: 23822919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does obesity impact the success of an InterStim test phase for the treatment of refractory urge urinary incontinence in female patients?
    Levin PJ; Wu JM; Siddiqui NY; Amundsen CL
    Female Pelvic Med Reconstr Surg; 2012; 18(4):243-6. PubMed ID: 22777375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary prevention with defibrillator therapy in women: results from the Sudden Cardiac Death in Heart Failure Trial.
    Russo AM; Poole JE; Mark DB; Anderson J; Hellkamp AS; Lee KL; Johnson GW; Domanski M; Bardy GH
    J Cardiovasc Electrophysiol; 2008 Jul; 19(7):720-4. PubMed ID: 18373605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Are MADIT II criteria for implantable cardioverter defibrillator implantation appropriate for Chinese patients?
    Siu CW; Pong V; Ho HH; Liu S; Lau CP; Li SW; Tse HF
    J Cardiovasc Electrophysiol; 2010 Mar; 21(3):231-5. PubMed ID: 19804551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac resynchronization therapy: do patient selection and implant practice vary depending on the volume a center handles?
    Hernández Madrid A; Matía Francés R; Moro C; Zamorano J
    Pacing Clin Electrophysiol; 2013 Jul; 36(7):863-71. PubMed ID: 23594313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The efficacy and safety of cardiac resynchronization therapy combined with implantable cardioverter defibrillator for heart failure: a meta-analysis of 5674 patients.
    Chen S; Ling Z; Kiuchi MG; Yin Y; Krucoff MW
    Europace; 2013 Jul; 15(7):992-1001. PubMed ID: 23419662
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complications of implantable cardioverter defibrillator therapy in 440 consecutive patients.
    Alter P; Waldhans S; Plachta E; Moosdorf R; Grimm W
    Pacing Clin Electrophysiol; 2005 Sep; 28(9):926-32. PubMed ID: 16176531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Causes and consequences of heart failure after prophylactic implantation of a defibrillator in the multicenter automatic defibrillator implantation trial II.
    Goldenberg I; Moss AJ; Hall WJ; McNitt S; Zareba W; Andrews ML; Cannom DS;
    Circulation; 2006 Jun; 113(24):2810-7. PubMed ID: 16769917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiac resynchronization therapy in patients with permanent atrial fibrillation: results from the Resynchronization for Ambulatory Heart Failure Trial (RAFT).
    Healey JS; Hohnloser SH; Exner DV; Birnie DH; Parkash R; Connolly SJ; Krahn AD; Simpson CS; Thibault B; Basta M; Philippon F; Dorian P; Nair GM; Sivakumaran S; Yetisir E; Wells GA; Tang AS;
    Circ Heart Fail; 2012 Sep; 5(5):566-70. PubMed ID: 22896584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of cardiac resynchronisation therapy on occurrence of ventricular arrhythmia in patients with implantable cardioverter defibrillators undergoing upgrade to cardiac resynchronisation therapy devices.
    Lin G; Rea RF; Hammill SC; Hayes DL; Brady PA
    Heart; 2008 Feb; 94(2):186-90. PubMed ID: 17761506
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of successful defibrillation threshold test during CRT-D implantation.
    Przybylski A; Oreziak A; Lewandowski Z; Hasiec A; Orczykowski M; Walczak F
    Kardiol Pol; 2010 May; 68(5):512-8. PubMed ID: 20491010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.